Home
AURA
AURA News

Latest Aura Biosciences Inc. (AURA) News on September 8, 2025

MT Newswires

4 months ago

Aura Biosciences Prices $75 Million Offering of Shares, Warrants

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

GlobeNewswire

4 months ago

Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants

MT Newswires

4 months ago

Aura Biosciences Launches Proposed Public Offering of Shares, Warrants

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

GlobeNewswire

4 months ago

Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

GlobeNewswire

4 months ago

Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

4 months ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?

Insider Monkey

5 months ago

Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

GlobeNewswire

5 months ago

Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

GlobeNewswire

5 months ago

Aura Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

MT Newswires

5 months ago

Aura Biosciences Reports 'Robust' Anti-Tumor Immune Response From Phase 1 Trial of Bel-sar in Non-Muscle-Invasive Bladder Cancer

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

GlobeNewswire

5 months ago

Positive Data from Phase 1 Trial of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) Presented at the 40th Annual European Association of Urology Congress

With 48% stake, Aura Biosciences, Inc. (NASDAQ:AURA) seems to have captured institutional investors' interest

Simply Wall St.

5 months ago

With 48% stake, Aura Biosciences, Inc. (NASDAQ:AURA) seems to have captured institutional investors' interest

MT Newswires

6 months ago

Top Premarket Gainers

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

GlobeNewswire

6 months ago

Aura Biosciences Announces Additional Data from Ongoing Phase 1 Trial in Non-Muscle Invasive Bladder Cancer to be Presented as a Late-Breaking Abstract at the 40th Annual European Association of Urology Congress

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

6 months ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Companies Like Aura Biosciences (NASDAQ:AURA) Are In A Position To Invest In Growth

Simply Wall St.

7 months ago

Companies Like Aura Biosciences (NASDAQ:AURA) Are In A Position To Invest In Growth

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

GlobeNewswire

9 months ago

Aura Biosciences to Participate in the 7th Annual Evercore ISI HealthCONx Conference

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

10 months ago

Aura Biosciences Reports Third Quarter 2024 Financial Results and Business Highlights

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

Simply Wall St.

10 months ago

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

MT Newswires

a year ago

Aura Biosciences Insider Sold Shares Worth $300,839, According to a Recent SEC Filing

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

GlobeNewswire

a year ago

Multiple Clinical Complete Responses Demonstrated Following Single Low Dose Administration of Bel-sar in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC) in Ongoing Phase 1 Trial

Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58%

Simply Wall St.

a year ago

Aura Biosciences, Inc. (NASDAQ:AURA) is a favorite amongst institutional investors who own 58%

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study

Zacks

a year ago

Aura Stock Up as Lead Drug Shows Superior Efficacy in Eye Cancer Study

MT Newswires

a year ago

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires

a year ago

Aura Biosciences' Eye Cancer Therapy Shows Promise in Mid-Stage Study -- Shares Rise Pre-Bell

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

GlobeNewswire

a year ago

Aura Biosciences Reports Positive Phase 2 End of Study Results Evaluating Bel-sar as a First-Line Treatment for Early-Stage Choroidal Melanoma

MT Newswires

a year ago

LifeSci Initiates Aura Biosciences at Outperform With $23 Price Target

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024

GlobeNewswire

a year ago

Aura Biosciences to Host a Urologic Oncology Investor Event to Present Early Non-Muscle Invasive Bladder Cancer (NMIBC) Data from its Ongoing Phase 1 Trial on Thursday, October 17, 2024

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting

GlobeNewswire

a year ago

Aura Biosciences Announces the Presentation of Phase 2 End of Study Data Evaluating Suprachoroidal Administration of Bel-sar for the First-Line Treatment of Patients with Early-Stage Choroidal Melanoma at The Retina Society Annual Meeting

Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

a year ago

Aura Biosciences Reports Second Quarter 2024 Financial Results and Business Highlights

MT Newswires

a year ago

HC Wainwright Starts Aura Biosciences With Buy Rating, $21 Price Target

Wall Street Analysts See a 162.63% Upside in Aura Biosciences (AURA): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See a 162.63% Upside in Aura Biosciences (AURA): Can the Stock Really Move This High?

Aura Biosciences to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Aura Biosciences to Participate in the Jefferies Global Healthcare Conference

Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024

GlobeNewswire

a year ago

Aura Biosciences to Host Virtual KOL Event “Pioneering a New Standard of Care In Ocular Oncology” on May 29, 2024

GuruFocus.com

a year ago

Aura Biosciences Inc (AURA) Reports Q1 2024 Earnings: A Detailed Financial Overview

Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire

a year ago

Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights

Aura Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire

a year ago

Aura Biosciences to Participate in Upcoming Investor Conferences

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

Simply Wall St.

a year ago

One Aura Biosciences Insider Raised Stake By 232% In Previous Year

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Simply Wall St.

a year ago

We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate

Business Wire

a year ago

Aura Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights

11 Oversold Biotech Stocks To Buy Right Now

Insider Monkey

a year ago

11 Oversold Biotech Stocks To Buy Right Now

Business Wire

2 years ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

‘Kubrick’ Review: The Perfectionist and His Craft

The Wall Street Journal

2 years ago

‘Kubrick’ Review: The Perfectionist and His Craft

Mercantile Bank (NASDAQ:MBWM) Is Increasing Its Dividend To $0.35

Simply Wall St.

2 years ago

Mercantile Bank (NASDAQ:MBWM) Is Increasing Its Dividend To $0.35

Analysts Estimate A-Mark Precious Metals (AMRK) to Report a Decline in Earnings: What to Look Out for

Zacks

2 years ago

Analysts Estimate A-Mark Precious Metals (AMRK) to Report a Decline in Earnings: What to Look Out for

Associated Press Finance

2 years ago

Flushing Financial: Q4 Earnings Snapshot

Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan

GlobeNewswire

2 years ago

Flushing Financial Corporation Reports 2023 and 4Q23 GAAP EPS of $0.96 and $0.27, and Core EPS of $0.83 and $0.25, Respectively; Continues to Successfully Execute On Its Action Plan

Associated Press Finance

2 years ago

Kearny: Fiscal Q2 Earnings Snapshot

Kearny Financial Corp. Announces Second Quarter Fiscal 2024 Results and Declaration of Cash Dividend

GlobeNewswire

2 years ago

Kearny Financial Corp. Announces Second Quarter Fiscal 2024 Results and Declaration of Cash Dividend

Q3 Earnings Highlights: Carrols (NASDAQ:TAST) Vs The Rest Of The Traditional Fast Food Stocks

StockStory

2 years ago

Q3 Earnings Highlights: Carrols (NASDAQ:TAST) Vs The Rest Of The Traditional Fast Food Stocks

Insider Sell: Cullinan Oncology Inc's Chief Business Officer Corrine Savill Sold 40,000 Shares

GuruFocus.com

2 years ago

Insider Sell: Cullinan Oncology Inc's Chief Business Officer Corrine Savill Sold 40,000 Shares

Piedmont Lithium (PLL) to Sell Portion of Its Atlantic Shares

Zacks

2 years ago

Piedmont Lithium (PLL) to Sell Portion of Its Atlantic Shares

ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the United States

GlobeNewswire

2 years ago

ZORYVE® (roflumilast) Topical Foam, 0.3%, for the Treatment of Seborrheic Dermatitis Launches in the United States

Basic Materials Roundup: Market Talk

The Wall Street Journal

2 years ago

Basic Materials Roundup: Market Talk

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

StockStory

2 years ago

Data Analytics Stocks Q3 Highlights: Palantir (NYSE:PLTR)

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

InvestorPlace

2 years ago

Are You Kidding Me? 3 Meme Stocks You Should Have Already Sold

MidWestOne Financial Group, Inc. Announces Fourth Quarter 2023 Earnings Conference Call

GlobeNewswire

2 years ago

MidWestOne Financial Group, Inc. Announces Fourth Quarter 2023 Earnings Conference Call

7 Overlooked Small-Cap Stocks to Keep On Your Radar

InvestorPlace

2 years ago

7 Overlooked Small-Cap Stocks to Keep On Your Radar

NRSInsights’ December 2023 Retail Same-Store Sales Report

GlobeNewswire

2 years ago

NRSInsights’ December 2023 Retail Same-Store Sales Report

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Simply Wall St.

2 years ago

Owning 48% shares,institutional owners seem interested in Aura Biosciences, Inc. (NASDAQ:AURA),

Owning 45% shares,institutional owners seem interested in Southern Missouri Bancorp, Inc. (NASDAQ:SMBC),

Simply Wall St.

2 years ago

Owning 45% shares,institutional owners seem interested in Southern Missouri Bancorp, Inc. (NASDAQ:SMBC),

7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World

InvestorPlace

2 years ago

7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World

12 Most Profitable Pot Stocks Now

Insider Monkey

2 years ago

12 Most Profitable Pot Stocks Now

Biotech CEOs Are Buying Up Their Surging Stocks

Barrons.com

2 years ago

Biotech CEOs Are Buying Up Their Surging Stocks

Forge Enhances Institutional Focus with Appointment of Chris Lane

Business Wire

2 years ago

Forge Enhances Institutional Focus with Appointment of Chris Lane

Savara Added to the NASDAQ Biotechnology Index

Business Wire

2 years ago

Savara Added to the NASDAQ Biotechnology Index

Uber Eats Teams Up with Gogoro in Taiwan for Green Delivery Program Worth Nearly $30M

PR Newswire

2 years ago

Uber Eats Teams Up with Gogoro in Taiwan for Green Delivery Program Worth Nearly $30M

IMAX Corporation's (NYSE:IMAX) Business Is Trailing The Industry But Its Shares Aren't

Simply Wall St.

2 years ago

IMAX Corporation's (NYSE:IMAX) Business Is Trailing The Industry But Its Shares Aren't

GlobeNewswire

2 years ago

Village Super Market, Inc. Declares Quarterly Dividend

GeoPark Limited (NYSE:GPRK) is largely controlled by institutional shareholders who own 52% of the company

Simply Wall St.

2 years ago

GeoPark Limited (NYSE:GPRK) is largely controlled by institutional shareholders who own 52% of the company

Wall Street Analysts Think Aura Biosciences, Inc. (AURA) Could Surge 174.29%: Read This Before Placing a Bet

Zacks

2 years ago

Wall Street Analysts Think Aura Biosciences, Inc. (AURA) Could Surge 174.29%: Read This Before Placing a Bet

Business Wire

2 years ago

Aura Biosciences Announces First Patient Dosed in Global Phase 3 CoMpass Trial Evaluating the Safety and Efficacy of Belzupacap Sarotalocan (Bel-sar) for First-Line Treatment of Early-Stage Choroidal Melanoma

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

GlobeNewswire

2 years ago

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

Associated Press Finance

2 years ago

Village Super Market: Fiscal Q1 Earnings Snapshot

GlobeNewswire

2 years ago

Village Super Market, Inc. Reports Results for the First Quarter Ended October 28, 2023

Shareholders in SmartFinancial (NASDAQ:SMBK) are in the red if they invested a year ago

Simply Wall St.

2 years ago

Shareholders in SmartFinancial (NASDAQ:SMBK) are in the red if they invested a year ago

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

PR Newswire

2 years ago

Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services

Algoma Steel Announces Retirement of Vice President - Sales

GlobeNewswire

2 years ago

Algoma Steel Announces Retirement of Vice President - Sales

Insider Sell: Executive Vice President Olivier Thirot Sells 30,000 Shares of Kelly Services Inc ...

GuruFocus.com

2 years ago

Insider Sell: Executive Vice President Olivier Thirot Sells 30,000 Shares of Kelly Services Inc ...

Wall Street Analysts Believe Aura Biosciences, Inc. (AURA) Could Rally 200.75%: Here's is How to Trade

Zacks

2 years ago

Wall Street Analysts Believe Aura Biosciences, Inc. (AURA) Could Rally 200.75%: Here's is How to Trade

Rick Hendrick Named Honoree at The Amelia in 2024

PR Newswire

2 years ago

Rick Hendrick Named Honoree at The Amelia in 2024

There's A Lot To Like About GeoPark's (NYSE:GPRK) Upcoming US$0.13 Dividend

Simply Wall St.

2 years ago

There's A Lot To Like About GeoPark's (NYSE:GPRK) Upcoming US$0.13 Dividend

Flagstar Bank sues Hometown Lenders for $21M

Banking Dive

2 years ago

Flagstar Bank sues Hometown Lenders for $21M

A Look At The Intrinsic Value Of Village Super Market, Inc. (NASDAQ:VLGE.A)

Simply Wall St.

2 years ago

A Look At The Intrinsic Value Of Village Super Market, Inc. (NASDAQ:VLGE.A)

GlobeNewswire

2 years ago

Gravity Reports Third Quarter of 2023 Results and Business Updates

David Johnson Bought 232% More Shares In Aura Biosciences

Simply Wall St.

2 years ago

David Johnson Bought 232% More Shares In Aura Biosciences

Business Wire

2 years ago

Aura Biosciences Reports Third Quarter 2023 Financial Results and Provides Clinical Development and Operational Highlights

Business Wire

2 years ago

Aura Biosciences to Participate in Upcoming Investor Conferences

Business Wire

2 years ago

Aura Biosciences Announces Pricing of Public Offering of Common Stock

Share on Social Networks: